## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract; no access to full manuscript, figures, tables, or supplementary materials
- **Shared manuscript claim summary** The authors present DR-BERT, a compact protein language model pretrained on unannotated proteins, which predicts intrinsically disordered regions without explicit evolutionary or biophysical data. They claim significant improvement over existing methods on the CAID evaluation dataset and competitiveness on the CAID 2 dataset, attributing performance to pretraining and contextual information.
- **Visible evidence base** Abstract text only; no quantitative results, dataset details, model architecture specifics, or comparison methodology are provided
- **Missing materials affecting confidence** Full manuscript, all figures and tables, model code or availability statement, hyperparameter details, training data description, evaluation protocol, statistical significance tests, and baseline method specifications

## Reviewer
- **Overall assessment** The abstract presents a potentially valuable contribution to computational protein annotation, but the evidence provided is insufficient to evaluate the validity of the central claims. The performance improvements are stated without quantitative support, and the mechanism attributed to pretraining is not substantiated. The work may interest the protein bioinformatics community, but the case is not established from the supplied material.
- **Who would be interested in the results, and why** Researchers in protein bioinformatics, structural biology, and computational biology would be interested because accurate disorder prediction has broad utility in functional annotation and drug discovery. The claim of a compact model that avoids evolutionary and biophysical inputs could appeal to those seeking efficient and scalable annotation tools.
- **Major strengths** The proposed approach addresses a relevant problem with a potentially novel design choice, namely a compact language model pretrained on unannotated sequences. The claim of competitive performance on CAID benchmarks, if substantiated, would be of practical significance.
- **Major Concerns** The abstract lacks all quantitative evidence needed to assess the performance claims. No metrics, confidence intervals, or statistical tests are reported. The attribution of performance to pretraining and contextual information is presented as a conclusion without supporting analysis. The scope of evaluation is unclear, as the relationship between the CAID and CAID 2 datasets and the specific test cases is not described.
- **Minor Comments** The abstract would benefit from stating the model size and training data scale. The phrase "significant improvement" requires a statistical definition. The mechanism of contextual information is vague and should be clarified.
- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3
- **Assessment against Nature-style criteria** Originality is plausible but not verifiable from the abstract alone. Scientific importance is potentially high given the utility of disorder prediction, but the evidence does not yet demonstrate a meaningful advance. Interdisciplinary readership is likely, as the topic bridges machine learning and structural biology. Technical soundness cannot be assessed without quantitative results and methodological detail. Readability for nonspecialists is adequate, though the abstract assumes familiarity with CAID benchmarks and language model terminology.
- **Recommendation posture** Currently not established from the provided evidence. The claims may be supportable, but the abstract alone does not provide sufficient basis for evaluation.

### Major Concerns

- **Concern ID** R1-M1
- **Severity** Major
- **Blocking** Yes
- **Axis** Evidence sufficiency
- **Claim pointer** "DR-BERT demonstrates significant improvement over existing methods on the CAID evaluation dataset and outperforms competitors on two out of four test cases in the CAID 2 dataset"
- **Evidence pointer** Abstract, location not provided
- **Concern** The abstract reports performance outcomes without any numerical values, such as area under the curve, precision, recall, or F1 scores. No comparison table or figure is referenced. The term "significant improvement" is used without statistical testing or effect sizes.
- **Why it matters** The central claim of the paper is that DR-BERT outperforms existing methods. Without quantitative evidence, the reader cannot verify the magnitude or reliability of the reported improvement, and the claim is not falsifiable from the supplied material.
- **Resolution test** Provide performance metrics for DR-BERT and all baselines on the CAID and CAID 2 datasets, including confidence intervals or statistical significance tests. Specify the evaluation protocol and the number of independent runs.

- **Concern ID** R1-M2
- **Severity** Major
- **Blocking** Yes
- **Axis** Mechanistic attribution
- **Claim pointer** "This performance is due to the information learned during pretraining and DR-BERT's ability to use contextual information"
- **Evidence pointer** Abstract, location not provided
- **Concern** The abstract attributes the model's performance to pretraining and contextual information without presenting any ablation studies, feature analyses, or comparisons to models without pretraining. This causal claim is unsupported.
- **Why it matters** The stated mechanism is a key part of the contribution. If the performance gain actually arises from other factors, such as architecture choices or training data composition, the scientific conclusion would be misleading.
- **Resolution test** Include ablation experiments that remove pretraining or restrict contextual information, and show that performance degrades. Alternatively, provide analyses that directly link learned representations to disorder-relevant features.

- **Concern ID** R1-M3
- **Severity** Major
- **Blocking** Yes
- **Axis** Scope and generalizability
- **Claim pointer** "DR-BERT demonstrates significant improvement over existing methods on the CAID evaluation dataset and outperforms competitors on two out of four test cases in the CAID 2 dataset, while maintaining competitiveness in the others"
- **Evidence pointer** Abstract, location not provided
- **Concern** The evaluation scope is described only in terms of dataset names and a count of test cases. The abstract does not specify which methods were compared, how the test cases were defined, or whether the results are consistent across protein families or sequence lengths.
- **Why it matters** Without a clear description of the evaluation setup, the reader cannot judge whether the reported performance is robust or whether it reflects favorable selection of test cases. Generalizability to diverse protein sequences remains unclear.
- **Resolution test** Describe the full evaluation protocol, including the list of baseline methods, the definition of test cases, and the diversity of the test set. Report performance stratified by relevant protein properties if applicable.

### Minor Comments

- **Concern ID** R1-m1
- **Severity** Minor
- **Axis** Clarity
- **Affected element** Model description
- **Evidence pointer** Abstract, location not provided
- **Issue** The term "compact" is used to describe the model, but no parameter count or memory footprint is given.
- **Required correction** State the number of parameters or model size relative to existing tools.

- **Concern ID** R1-m2
- **Severity** Minor
- **Axis** Reproducibility
- **Affected element** Data and code availability
- **Evidence pointer** Abstract, location not provided
- **Issue** No mention is made of whether the model, training data, or evaluation scripts will be made publicly available.
- **Required correction** Add a statement on data and code availability in the abstract or refer to the full manuscript.

- **Concern ID** R1-m3
- **Severity** Minor
- **Axis** Terminology
- **Affected element** Statistical language
- **Evidence pointer** Abstract, location not provided
- **Issue** The phrase "significant improvement" is used without a statistical context.
- **Required correction** Replace with a quantitative statement or specify the statistical test used.

## Risk / unsupported claims
- The claim of "significant improvement" over existing methods is unsupported due to the absence of any reported metrics or statistical analysis.
- The attribution of performance to pretraining and contextual information is unsupported without ablation or mechanistic evidence.
- The claim of competitiveness on the CAID 2 dataset is not evaluable because the specific test cases and comparison methods are not described.
- The generalizability of the model to diverse protein sequences is not assessable from the abstract alone.